Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor “Dapagliflozin” after Cardiac Arrest and Cardiopulmonary Resuscitation: a Pilot Study

Daria De Giorgio(Mario Negri Institute for Pharmacological Research), Francesca Fumagalli(Vita-Salute San Raffaele University), Carlo Perego(Mario Negri Institute for Pharmacological Research), Marianna Cerrato(Mario Negri Institute for Pharmacological Research), Francesca Callegari(University of Genoa), Giuseppe Ristagno(Italian Resuscitation Council), Elisa R. Zanier(Mario Negri Institute for Pharmacological Research)
Resuscitation
October 1, 2025
Cited by 0


Related Papers